Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Abate As Indust
Quarter-by-quarter operating performance
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|
| Sales + | 0.00 | 0.00 | 0.00 | 14.09 | 41.06 | 42.13 | 42.69 |
| Expenses + | 0.04 | 0.03 | 0.02 | 13.28 | 38.56 | 38.28 | 38.76 |
| Operating Profit | -0.04 | -0.03 | -0.02 | 0.81 | 2.50 | 3.85 | 3.93 |
| OPM % | 5.75% | 6.09% | 9.14% | 9.21% | |||
| Other Income + | 0.00 | 0.00 | 0.00 | 0.97 | 0.51 | 1.13 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.17 | 0.15 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.55 | 0.49 | 0.52 | 0.52 |
| Profit before tax | -0.04 | -0.03 | -0.02 | 1.17 | 2.41 | 4.29 | 3.32 |
| Tax % | 0.00% | 0.00% | 0.00% | -1.71% | 6.64% | 5.13% | 8.43% |
| Net Profit + | -0.04 | -0.03 | -0.02 | 1.19 | 2.25 | 4.07 | 3.06 |
| EPS in Rs | -0.04 | -0.03 | -0.02 | 0.08 | 0.14 | 0.26 | 0.19 |
Financials of Abate As Indust
Annual income statement trend
| Mar 2025 | TTM | |
|---|---|---|
| Sales + | 14 | 140 |
| Expenses + | 13 | 129 |
| Operating Profit | 1 | 11 |
| OPM % | 5% | 8% |
| Other Income + | 1 | 3 |
| Interest | 0 | 0 |
| Depreciation | 1 | 2 |
| Profit before tax | 1 | 11 |
| Tax % | -2% | |
| Net Profit + | 1 | 11 |
| EPS in Rs | 0.07 | 0.67 |
| Dividend Payout % | 0% |
Financials of Abate As Indust
Capital structure and asset base
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 79 | 158 |
| Reserves | 85 | 12 |
| Borrowings + | 11 | 9 |
| Other Liabilities + | 31 | 36 |
| Total Liabilities | 206 | 215 |
| Fixed Assets + | 149 | 151 |
| CWIP | 0 | 0 |
| Investments | 14 | 14 |
| Other Assets + | 43 | 50 |
| Total Assets | 206 | 215 |
Financials of Abate As Indust
Operating, investing and financing cash movement
| Mar 2025 | |
|---|---|
| Cash from Operating Activity + | -1 |
| Cash from Investing Activity + | -162 |
| Cash from Financing Activity + | 165 |
| Net Cash Flow | 2 |
| Free Cash Flow | -1 |
| CFO/OP | -91% |
Financials of Abate As Indust
Working capital efficiency and return ratios
| Mar 2025 | |
|---|---|
| Debtor Days | 430 |
| Inventory Days | 413 |
| Days Payable | 209 |
| Cash Conversion Cycle | 635 |
| Working Capital Days | 640 |
| ROCE % |
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…